Home › Funds › Atle Fund Management AB › IDYA
Atle Fund Management AB position in IDYA
IDEAYA BIOSCIENCES INC · Health Care
Atle Fund Management AB reported holding 93,550 shares of IDYA (IDEAYA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 0.96% of its reported portfolio and ranking #32 among its reported holdings. Atle Fund Management AB has disclosed IDYA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Atle Fund Management AB's IDYA position evolved
Atle Fund Management AB first disclosed a stake in IDYA in Q4 2025 at 97,438 shares (US$3.4M). The position peaked in Q1 2026 at 31,133 shares, worth US$4.0M. Across 4 filings, Atle Fund Management AB increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 93,550 shares valued at US$3.6M — a reduction of -928 shares quarter over quarter.. Notable position changes include a 68% trim in Q1 2026 (shares rose 12% over the following quarter), a 203% increase in Q2 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 97.44K | $3.37M | New |
| Q1 2026 | 31.13K | $4.01M | Reduce |
| Q2 2026 | 94.48K | $3.52M | Add |
| Q3 2026 | 93.55K | $3.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IDYA and 13F data
IDYA (IDEAYA BIOSCIENCES INC) is a Health Care company. 38 other funds we track also report a position in IDYA — the largest reported positions include BAKER BROS. ADVISORS LP (US$186.7M), Logos Global Management LP (US$111.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$101.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IDYA
- BAKER BROS. ADVISORS LP 5.01M sh · $186.72M · Q2 2026
- Logos Global Management LP 3.00M sh · $111.81M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.71M sh · $101.17M · Q2 2026
- GSK plc 1.33M sh · $51.23M · Q3 2026
- Sofinnova Investments, Inc. 925.12K sh · $34.48M · Q2 2026
- Redmile Group, LLC 640.20K sh · $23.86M · Q2 2026
More on Atle Fund Management AB
FAQ
How long has Atle Fund Management AB held IDYA?
Atle Fund Management AB has disclosed IDYA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Atle Fund Management AB's current position in IDYA?
As of Q3 2026, Atle Fund Management AB holds 93.55K shares of IDYA (IDEAYA BIOSCIENCES INC), valued at $3.59M, representing 0.96% of its reported portfolio and ranking #32.
Has Atle Fund Management AB been buying or selling IDYA?
In the latest 13F filing (Q3 2026), Atle Fund Management AB reduced its position in IDYA. The position peaked in Q1 2026 at 31.13K shares.
Which other funds hold IDYA?
Other major institutional holders of IDYA include BAKER BROS. ADVISORS LP, Logos Global Management LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.